Randomized sub-trial 1 of a global adaptive platform trial of COM701 maintenance therapy in patients with relapsed platinum sensitive ovarian cancer Trial supported by strong ...

HanchorBio Inc. (TPEx: 7827.TWO), a pioneer of immunotherapy biologics, is announcing its official listing on the Taipei Exchange (TPEx) Emerging Stock Board under the ticker symbol 7827.TWO and the ...

The efficacy of immunotherapy targeting PD-1/PD-L1 in gastric cancer depends on PD-L1 expression levels and the infiltration of immune cells within the tumor microenvironment (TME).

A high-fiber diet may improve response rates and event-free survival outcomes in patients with advanced melanoma receiving standard immunotherapy.

FDA removes CAR-T access barriers in move set to boost cancer immunotherapy uptake By Angus Liu Jun 27, 2025 11:14am U.S. FDA Cell & Gene Therapy CAR-T drug safety ...

80% of colorectal cancers resist immunotherapy—this DNA treatment could help by Gillian Rutherford, University of Alberta edited by Lisa Lock, reviewed by Robert Egan Editors' notes ...